By Audrey Burton-Bethke | Posted - May 6th, 2021





Don't Miss this: Getting to Know the Abecma (ide-cel) CAR T Therapy MC Community Event

The newly FDA-approved treatment, Abecma (ide-cel) CAR T Therapy, has been a popular topic of myeloma-based meetings and articles in recent months. So what will make this upcoming event in the Myeloma Crowd Community any different? 

We wanted to take a more basic approach when considering the CAR T therapy. We will explore practical questions surrounding CAR T therapy such as: 

  • What is the treatment? 
  • How does it work? 
  • Who is it for? 
  • What is the procedure like? 
  • Who qualifies for it? 
  • How can you sign up? 
  • What is recovery like? 

And to answer these questions we have multiple myeloma specialist, Dr. Nina Shah from UCSF Health. With experience in the CAR T clinical trials, Dr. Shah has a unique perspective on the treatment and will be able to share her knowledge with us in a clear and precise way. 

Don't miss the chance to ask an expert your questions about this new and upcoming therapy. It could be a game-changer in your myeloma journey! 


Register Today!




Audrey Burton-Bethke
About the Author

Audrey Burton-Bethke - Audrey joined the Myeloma Crowd as the Community Manager in 2020 after previously working in the nonprofit field for 4 years as a director of Fundraising and Development. She graduated from BYU with a major in Spanish and Nonprofit Management. Audrey is passionate about serving others, loves learning, and enjoys a nice mug of hot chocolate no matter the weather.


Add a Comment



Thanks to our Myeloma Crowd Community sponsors:

.                         .       .